Vedolizumab
CPT4 code
Name of the Procedure:
Vedolizumab Infusion
Summary
Vedolizumab is a medication administered via intravenous infusion, often used to treat inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis. The infusion typically involves delivering the drug directly into the bloodstream over a set period.
Purpose
Vedolizumab is used to reduce inflammation and manage the symptoms of IBD. It aims to induce and maintain remission, improve the patient’s quality of life, and minimize the need for corticosteroids.
Indications
Patients might qualify for Vedolizumab if they have moderate to severe Crohn's disease or ulcerative colitis that hasn't responded well to other treatments. Symptoms can include severe abdominal pain, chronic diarrhea, and weight loss.
Preparation
Patients should discuss their current medications with their healthcare provider to avoid interactions. Blood tests and other diagnostic assessments might be required before starting Vedolizumab therapy. No specific fasting or other special preparations are usually necessary.
Procedure Description
- Check-in: The patient arrives at the healthcare facility and checks in.
- Pre-infusion: A nurse conducts a brief health assessment and may insert an IV cannula.
- Infusion: Vedolizumab is infused into the bloodstream through the IV over approximately 30-60 minutes.
- Monitoring: Post-infusion, the patient will be monitored for a short period to observe any immediate adverse reactions.
No sedation or anesthesia is required for this procedure.
Duration
The infusion process typically takes around 30-60 minutes, with additional time for preparation and monitoring.
Setting
Vedolizumab infusions are usually performed in a hospital infusion center or outpatient clinic.
Personnel
The procedure typically involves a registered nurse who administers the infusion and monitors the patient. A physician oversees the treatment plan.
Risks and Complications
Common risks include headaches, nausea, joint pain, and reaction at the infusion site. Rare but serious complications can include severe allergic reactions, infections, and liver issues.
Benefits
The expected benefits include reduced intestinal inflammation, fewer flare-ups, and overall symptom relief. Patients usually start to see improvements within a few weeks to a few months of starting treatment.
Recovery
After the infusion, patients can typically resume their normal activities right away. Follow-up appointments are necessary to monitor the drug's effectiveness and any potential side effects.
Alternatives
Alternatives may include other biologic therapies, corticosteroids, immunomodulators, or surgical options. Each treatment has its advantages and disadvantages, which should be discussed with the healthcare provider.
Patient Experience
During the procedure, patients may feel a slight pinch from the IV insertion and minor discomfort at the infusion site. Post-infusion, patients might experience mild side effects, but these are generally manageable with support from healthcare providers. Pain management and comfort measures are available if needed.